ID   PC-3M-2B4
AC   CVCL_G256
SY   PC-3M 2B4; PC3M-2B4; 2B4-L; 2B4
DR   cancercelllines; CVCL_G256
DR   CCRID; 1101HUM-PUMC000200
DR   CCRID; 4201HUM-CCTCC00331
DR   CCTCC; GDC0331
DR   Wikidata; Q54938437
RX   PubMed=18060641;
RX   PubMed=20388373;
CC   Population: Caucasian.
CC   Characteristics: Low metastatic potential.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16,20
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24,25
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 17
//
RX   PubMed=18060641; DOI=10.1007/s11596-007-0527-x;
RA   Song A.-P., Liao G.-N., Wu M.-F., Lu Y.-P., Ma D.;
RT   "Screening of differently expressed genes in human prostate cancer
RT   cell lines with different metastasis potentials.";
RL   J. Huazhong Univ. Sci. Technol. Med. Sci. 27:582-585(2007).
//
RX   PubMed=20388373; DOI=10.3760/cma.j.issn.0529-5807.2010.02.005;
RA   Yu W.-J., Wang Y.-W., Xie Z.-G., You J.-F., Wang J.-L., Cui X.-L.,
RA   Pei F., Zheng J.;
RT   "Screening of phosphoprotein associated with glycosphingolipid
RT   microdomains 1 (PAG1) by cDNA microarray and influence of
RT   overexpression of PAG1 on biologic behavior of human metastatic
RT   prostatic cancer cell line in vitro.";
RL   Zhonghua Bing Li Xue Za Zhi 39:88-94(2010).
//